English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 93 | Tables: 97 | Pharma & Healthcare
The global market for Powder for Inhalation was valued at US$ 13670 million in the year 2024 and is projected to reach a revised size of US$ 18628 million by 2031, growing at a CAGR of 4.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Powder for Inhalation competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Powder for inhalation (used in dry powder inhalers, DPIs) delivers active pharmaceutical ingredients as respirable powders driven by patient inhalation and is widely used for local treatment of respiratory diseases (asthma, COPD) and selected systemic applications (e.g., inhaled insulin). Key technical challenges are particle-size distribution, powder flow/dispersibility, physical stability and device–formulation compatibility (capsule-based, blister, or multi-dose devices); common manufacturing technologies include spray-drying, spray-freeze-drying and particle-engineering approaches to achieve the required aerosol performance. Upstream inputs include inhalation-grade APIs (with tight impurity/residual-solvent specs) and lung-safe excipients — lactose remains the predominant carrier in many commercial formulations — and many projects outsource formulation development and scale-up to specialized CDMOs.
In 2024, the global market average price for Powder for Inhalation was USD 26.7 per unit, with a total sales volume of 512 million units.
North American market for Powder for Inhalation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Powder for Inhalation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Powder for Inhalation include GSK, Novartis, AstraZeneca, Chiesi Farmaceutici, Teva Pharmaceutical, Sumitomo Pharma, Cipla, Glenmark Pharmaceuticals, Orion Corporation, Bausch Health, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Powder for Inhalation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powder for Inhalation.
The Powder for Inhalation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Powder for Inhalation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Powder for Inhalation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Novartis
AstraZeneca
Chiesi Farmaceutici
Teva Pharmaceutical
Sumitomo Pharma
Cipla
Glenmark Pharmaceuticals
Orion Corporation
Bausch Health
Viatris
Zhejiang Xianjun Pharmaceutical
Shanghai Pharmaceuticals
Chia Tai Tianqing Pharmaceutical
Segment by Type
Tiotropium Bromide
Salbutamol Sulfate
Beclomethasone Dipropionate
Others
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Powder for Inhalation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Powder for Inhalation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Powder for Inhalation Market Overview
1.1 Product Definition
1.2 Powder for Inhalation by Type
1.2.1 Global Powder for Inhalation Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tiotropium Bromide
1.2.3 Salbutamol Sulfate
1.2.4 Beclomethasone Dipropionate
1.2.5 Others
1.3 Powder for Inhalation by Application
1.3.1 Global Powder for Inhalation Market Value by Application (2024 VS 2031)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Powder for Inhalation Market Size Estimates and Forecasts
1.4.1 Global Powder for Inhalation Revenue 2020-2031
1.4.2 Global Powder for Inhalation Sales 2020-2031
1.4.3 Global Powder for Inhalation Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Powder for Inhalation Market Competition by Manufacturers
2.1 Global Powder for Inhalation Sales Market Share by Manufacturers (2020-2025)
2.2 Global Powder for Inhalation Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Powder for Inhalation Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Powder for Inhalation, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Powder for Inhalation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Powder for Inhalation, Product Type & Application
2.7 Global Key Manufacturers of Powder for Inhalation, Date of Enter into This Industry
2.8 Global Powder for Inhalation Market Competitive Situation and Trends
2.8.1 Global Powder for Inhalation Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Powder for Inhalation Players Market Share by Revenue
2.8.3 Global Powder for Inhalation Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Powder for Inhalation Market Scenario by Region
3.1 Global Powder for Inhalation Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Powder for Inhalation Sales by Region: 2020-2031
3.2.1 Global Powder for Inhalation Sales by Region: 2020-2025
3.2.2 Global Powder for Inhalation Sales by Region: 2026-2031
3.3 Global Powder for Inhalation Revenue by Region: 2020-2031
3.3.1 Global Powder for Inhalation Revenue by Region: 2020-2025
3.3.2 Global Powder for Inhalation Revenue by Region: 2026-2031
3.4 North America Powder for Inhalation Market Facts & Figures by Country
3.4.1 North America Powder for Inhalation Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Powder for Inhalation Sales by Country (2020-2031)
3.4.3 North America Powder for Inhalation Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Powder for Inhalation Market Facts & Figures by Country
3.5.1 Europe Powder for Inhalation Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Powder for Inhalation Sales by Country (2020-2031)
3.5.3 Europe Powder for Inhalation Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Powder for Inhalation Market Facts & Figures by Region
3.6.1 Asia Pacific Powder for Inhalation Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Powder for Inhalation Sales by Region (2020-2031)
3.6.3 Asia Pacific Powder for Inhalation Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Powder for Inhalation Market Facts & Figures by Country
3.7.1 Latin America Powder for Inhalation Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Powder for Inhalation Sales by Country (2020-2031)
3.7.3 Latin America Powder for Inhalation Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Powder for Inhalation Market Facts & Figures by Country
3.8.1 Middle East and Africa Powder for Inhalation Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Powder for Inhalation Sales by Country (2020-2031)
3.8.3 Middle East and Africa Powder for Inhalation Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Powder for Inhalation Sales by Type (2020-2031)
4.1.1 Global Powder for Inhalation Sales by Type (2020-2025)
4.1.2 Global Powder for Inhalation Sales by Type (2026-2031)
4.1.3 Global Powder for Inhalation Sales Market Share by Type (2020-2031)
4.2 Global Powder for Inhalation Revenue by Type (2020-2031)
4.2.1 Global Powder for Inhalation Revenue by Type (2020-2025)
4.2.2 Global Powder for Inhalation Revenue by Type (2026-2031)
4.2.3 Global Powder for Inhalation Revenue Market Share by Type (2020-2031)
4.3 Global Powder for Inhalation Price by Type (2020-2031)
5 Segment by Application
5.1 Global Powder for Inhalation Sales by Application (2020-2031)
5.1.1 Global Powder for Inhalation Sales by Application (2020-2025)
5.1.2 Global Powder for Inhalation Sales by Application (2026-2031)
5.1.3 Global Powder for Inhalation Sales Market Share by Application (2020-2031)
5.2 Global Powder for Inhalation Revenue by Application (2020-2031)
5.2.1 Global Powder for Inhalation Revenue by Application (2020-2025)
5.2.2 Global Powder for Inhalation Revenue by Application (2026-2031)
5.2.3 Global Powder for Inhalation Revenue Market Share by Application (2020-2031)
5.3 Global Powder for Inhalation Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Powder for Inhalation Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Powder for Inhalation Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Powder for Inhalation Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Chiesi Farmaceutici
6.4.1 Chiesi Farmaceutici Company Information
6.4.2 Chiesi Farmaceutici Description and Business Overview
6.4.3 Chiesi Farmaceutici Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chiesi Farmaceutici Powder for Inhalation Product Portfolio
6.4.5 Chiesi Farmaceutici Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Company Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Powder for Inhalation Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Sumitomo Pharma
6.6.1 Sumitomo Pharma Company Information
6.6.2 Sumitomo Pharma Description and Business Overview
6.6.3 Sumitomo Pharma Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sumitomo Pharma Powder for Inhalation Product Portfolio
6.6.5 Sumitomo Pharma Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Powder for Inhalation Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Glenmark Pharmaceuticals
6.8.1 Glenmark Pharmaceuticals Company Information
6.8.2 Glenmark Pharmaceuticals Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glenmark Pharmaceuticals Powder for Inhalation Product Portfolio
6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.9 Orion Corporation
6.9.1 Orion Corporation Company Information
6.9.2 Orion Corporation Description and Business Overview
6.9.3 Orion Corporation Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Orion Corporation Powder for Inhalation Product Portfolio
6.9.5 Orion Corporation Recent Developments/Updates
6.10 Bausch Health
6.10.1 Bausch Health Company Information
6.10.2 Bausch Health Description and Business Overview
6.10.3 Bausch Health Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bausch Health Powder for Inhalation Product Portfolio
6.10.5 Bausch Health Recent Developments/Updates
6.11 Viatris
6.11.1 Viatris Company Information
6.11.2 Viatris Description and Business Overview
6.11.3 Viatris Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Viatris Powder for Inhalation Product Portfolio
6.11.5 Viatris Recent Developments/Updates
6.12 Zhejiang Xianjun Pharmaceutical
6.12.1 Zhejiang Xianjun Pharmaceutical Company Information
6.12.2 Zhejiang Xianjun Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product Portfolio
6.12.5 Zhejiang Xianjun Pharmaceutical Recent Developments/Updates
6.13 Shanghai Pharmaceuticals
6.13.1 Shanghai Pharmaceuticals Company Information
6.13.2 Shanghai Pharmaceuticals Description and Business Overview
6.13.3 Shanghai Pharmaceuticals Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Pharmaceuticals Powder for Inhalation Product Portfolio
6.13.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.14 Chia Tai Tianqing Pharmaceutical
6.14.1 Chia Tai Tianqing Pharmaceutical Company Information
6.14.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.14.3 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product Portfolio
6.14.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Powder for Inhalation Industry Chain Analysis
7.2 Powder for Inhalation Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Powder for Inhalation Production Mode & Process Analysis
7.4 Powder for Inhalation Sales and Marketing
7.4.1 Powder for Inhalation Sales Channels
7.4.2 Powder for Inhalation Distributors
7.5 Powder for Inhalation Customer Analysis
8 Powder for Inhalation Market Dynamics
8.1 Powder for Inhalation Industry Trends
8.2 Powder for Inhalation Market Drivers
8.3 Powder for Inhalation Market Challenges
8.4 Powder for Inhalation Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Powder for Inhalation Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Powder for Inhalation Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Powder for Inhalation Market Competitive Situation by Manufacturers in 2024
Table 4. Global Powder for Inhalation Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Powder for Inhalation Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Powder for Inhalation Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Powder for Inhalation Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Powder for Inhalation Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Powder for Inhalation, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Powder for Inhalation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Powder for Inhalation, Product Type & Application
Table 12. Global Key Manufacturers of Powder for Inhalation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Powder for Inhalation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powder for Inhalation as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Powder for Inhalation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Powder for Inhalation Sales by Region (2020-2025) & (K Units)
Table 18. Global Powder for Inhalation Sales Market Share by Region (2020-2025)
Table 19. Global Powder for Inhalation Sales by Region (2026-2031) & (K Units)
Table 20. Global Powder for Inhalation Sales Market Share by Region (2026-2031)
Table 21. Global Powder for Inhalation Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Powder for Inhalation Revenue Market Share by Region (2020-2025)
Table 23. Global Powder for Inhalation Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Powder for Inhalation Revenue Market Share by Region (2026-2031)
Table 25. North America Powder for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Powder for Inhalation Sales by Country (2020-2025) & (K Units)
Table 27. North America Powder for Inhalation Sales by Country (2026-2031) & (K Units)
Table 28. North America Powder for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Powder for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Powder for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Powder for Inhalation Sales by Country (2020-2025) & (K Units)
Table 32. Europe Powder for Inhalation Sales by Country (2026-2031) & (K Units)
Table 33. Europe Powder for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Powder for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Powder for Inhalation Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Powder for Inhalation Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Powder for Inhalation Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Powder for Inhalation Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Powder for Inhalation Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Powder for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Powder for Inhalation Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Powder for Inhalation Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Powder for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Powder for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Powder for Inhalation Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Powder for Inhalation Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Powder for Inhalation Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Powder for Inhalation Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Powder for Inhalation Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Powder for Inhalation Sales (K Units) by Type (2020-2025)
Table 51. Global Powder for Inhalation Sales (K Units) by Type (2026-2031)
Table 52. Global Powder for Inhalation Sales Market Share by Type (2020-2025)
Table 53. Global Powder for Inhalation Sales Market Share by Type (2026-2031)
Table 54. Global Powder for Inhalation Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Powder for Inhalation Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Powder for Inhalation Revenue Market Share by Type (2020-2025)
Table 57. Global Powder for Inhalation Revenue Market Share by Type (2026-2031)
Table 58. Global Powder for Inhalation Price (US$/Unit) by Type (2020-2025)
Table 59. Global Powder for Inhalation Price (US$/Unit) by Type (2026-2031)
Table 60. Global Powder for Inhalation Sales (K Units) by Application (2020-2025)
Table 61. Global Powder for Inhalation Sales (K Units) by Application (2026-2031)
Table 62. Global Powder for Inhalation Sales Market Share by Application (2020-2025)
Table 63. Global Powder for Inhalation Sales Market Share by Application (2026-2031)
Table 64. Global Powder for Inhalation Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Powder for Inhalation Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Powder for Inhalation Revenue Market Share by Application (2020-2025)
Table 67. Global Powder for Inhalation Revenue Market Share by Application (2026-2031)
Table 68. Global Powder for Inhalation Price (US$/Unit) by Application (2020-2025)
Table 69. Global Powder for Inhalation Price (US$/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GSK Powder for Inhalation Product
Table 74. GSK Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Powder for Inhalation Product
Table 79. Novartis Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Powder for Inhalation Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Chiesi Farmaceutici Company Information
Table 86. Chiesi Farmaceutici Description and Business Overview
Table 87. Chiesi Farmaceutici Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Chiesi Farmaceutici Powder for Inhalation Product
Table 89. Chiesi Farmaceutici Recent Developments/Updates
Table 90. Teva Pharmaceutical Company Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Powder for Inhalation Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Sumitomo Pharma Company Information
Table 96. Sumitomo Pharma Description and Business Overview
Table 97. Sumitomo Pharma Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sumitomo Pharma Powder for Inhalation Product
Table 99. Sumitomo Pharma Recent Developments/Updates
Table 100. Cipla Company Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Cipla Powder for Inhalation Product
Table 104. Cipla Recent Developments/Updates
Table 105. Glenmark Pharmaceuticals Company Information
Table 106. Glenmark Pharmaceuticals Description and Business Overview
Table 107. Glenmark Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Glenmark Pharmaceuticals Powder for Inhalation Product
Table 109. Glenmark Pharmaceuticals Recent Developments/Updates
Table 110. Orion Corporation Company Information
Table 111. Orion Corporation Description and Business Overview
Table 112. Orion Corporation Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Orion Corporation Powder for Inhalation Product
Table 114. Orion Corporation Recent Developments/Updates
Table 115. Bausch Health Company Information
Table 116. Bausch Health Description and Business Overview
Table 117. Bausch Health Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bausch Health Powder for Inhalation Product
Table 119. Bausch Health Recent Developments/Updates
Table 120. Viatris Company Information
Table 121. Viatris Description and Business Overview
Table 122. Viatris Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Viatris Powder for Inhalation Product
Table 124. Viatris Recent Developments/Updates
Table 125. Zhejiang Xianjun Pharmaceutical Company Information
Table 126. Zhejiang Xianjun Pharmaceutical Description and Business Overview
Table 127. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhejiang Xianjun Pharmaceutical Powder for Inhalation Product
Table 129. Zhejiang Xianjun Pharmaceutical Recent Developments/Updates
Table 130. Shanghai Pharmaceuticals Company Information
Table 131. Shanghai Pharmaceuticals Description and Business Overview
Table 132. Shanghai Pharmaceuticals Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shanghai Pharmaceuticals Powder for Inhalation Product
Table 134. Shanghai Pharmaceuticals Recent Developments/Updates
Table 135. Chia Tai Tianqing Pharmaceutical Company Information
Table 136. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 137. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Chia Tai Tianqing Pharmaceutical Powder for Inhalation Product
Table 139. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Powder for Inhalation Distributors List
Table 143. Powder for Inhalation Customers List
Table 144. Powder for Inhalation Market Trends
Table 145. Powder for Inhalation Market Drivers
Table 146. Powder for Inhalation Market Challenges
Table 147. Powder for Inhalation Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Powder for Inhalation
Figure 2. Global Powder for Inhalation Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Powder for Inhalation Market Share by Type: 2024 & 2031
Figure 4. Tiotropium Bromide Product Picture
Figure 5. Salbutamol Sulfate Product Picture
Figure 6. Beclomethasone Dipropionate Product Picture
Figure 7. Others Product Picture
Figure 8. Global Powder for Inhalation Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Powder for Inhalation Market Share by Application: 2024 & 2031
Figure 10. Asthma
Figure 11. COPD
Figure 12. Others
Figure 13. Global Powder for Inhalation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Powder for Inhalation Market Size (2020-2031) & (US$ Million)
Figure 15. Global Powder for Inhalation Sales (2020-2031) & (K Units)
Figure 16. Global Powder for Inhalation Average Price (US$/Unit) & (2020-2031)
Figure 17. Powder for Inhalation Report Years Considered
Figure 18. Powder for Inhalation Sales Share by Manufacturers in 2024
Figure 19. Global Powder for Inhalation Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Powder for Inhalation Players: Market Share by Revenue in Powder for Inhalation in 2024
Figure 21. Powder for Inhalation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Powder for Inhalation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Powder for Inhalation Sales Market Share by Country (2020-2031)
Figure 24. North America Powder for Inhalation Revenue Market Share by Country (2020-2031)
Figure 25. United States Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Powder for Inhalation Sales Market Share by Country (2020-2031)
Figure 28. Europe Powder for Inhalation Revenue Market Share by Country (2020-2031)
Figure 29. Germany Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Powder for Inhalation Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Powder for Inhalation Revenue Market Share by Region (2020-2031)
Figure 36. China Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Powder for Inhalation Sales Market Share by Country (2020-2031)
Figure 44. Latin America Powder for Inhalation Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Powder for Inhalation Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Powder for Inhalation Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Powder for Inhalation Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Powder for Inhalation by Type (2020-2031)
Figure 55. Global Revenue Market Share of Powder for Inhalation by Type (2020-2031)
Figure 56. Global Powder for Inhalation Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Powder for Inhalation by Application (2020-2031)
Figure 58. Global Revenue Market Share of Powder for Inhalation by Application (2020-2031)
Figure 59. Global Powder for Inhalation Price (US$/Unit) by Application (2020-2031)
Figure 60. Powder for Inhalation Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
